PH12021553174A1 - Polymorphs of a macrocyclic kinase inhibitor - Google Patents
Polymorphs of a macrocyclic kinase inhibitorInfo
- Publication number
- PH12021553174A1 PH12021553174A1 PH1/2021/553174A PH12021553174A PH12021553174A1 PH 12021553174 A1 PH12021553174 A1 PH 12021553174A1 PH 12021553174 A PH12021553174 A PH 12021553174A PH 12021553174 A1 PH12021553174 A1 PH 12021553174A1
- Authority
- PH
- Philippines
- Prior art keywords
- polymorphs
- kinase inhibitor
- macrocyclic kinase
- mammals
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962863493P | 2019-06-19 | 2019-06-19 | |
| US202062959940P | 2020-01-11 | 2020-01-11 | |
| US202063036102P | 2020-06-08 | 2020-06-08 | |
| PCT/US2020/037892 WO2020257169A1 (en) | 2019-06-19 | 2020-06-16 | Polymorphs of a macrocyclic kinase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12021553174A1 true PH12021553174A1 (en) | 2022-08-01 |
Family
ID=74040102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2021/553174A PH12021553174A1 (en) | 2019-06-19 | 2020-06-16 | Polymorphs of a macrocyclic kinase inhibitor |
Country Status (15)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113336774B (zh) * | 2021-06-25 | 2023-05-23 | 江南大学 | 作为trk抑制剂的取代的手性二芳基大环化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015112806A2 (en) * | 2014-01-24 | 2015-07-30 | Tp Therapeutics, Inc. | Diaryl macrocycles as modulators of protein kinases |
| RU2732405C2 (ru) * | 2015-07-02 | 2020-09-16 | Тёрнинг Поинт Терапьютикс, Инк. | Хиральные диарильные макроциклы в качестве модуляторов протеинкиназ |
| BR112018000297A2 (pt) * | 2015-07-06 | 2018-09-04 | Tp Therapeutics Inc | polimorfo de macrociclo de diarila |
| WO2017015367A1 (en) * | 2015-07-21 | 2017-01-26 | Tp Therapeutics, Inc. | Chiral diaryl macrocycles and uses thereof |
| CA3069554A1 (en) * | 2017-07-14 | 2019-01-17 | Glaxosmithkline Intellectual Property Development Limited | Inhibitors of leucine rich repeat kinase 2 |
| RS63787B1 (sr) * | 2017-12-19 | 2022-12-30 | Turning Point Therapeutics Inc | Makrociklična jedinjenja za lečenje bolesti |
-
2020
- 2020-06-16 WO PCT/US2020/037892 patent/WO2020257169A1/en not_active Ceased
- 2020-06-16 MX MX2021015756A patent/MX2021015756A/es unknown
- 2020-06-16 US US17/618,060 patent/US20220411439A1/en not_active Abandoned
- 2020-06-16 JP JP2021575515A patent/JP2022537385A/ja not_active Withdrawn
- 2020-06-16 AU AU2020294627A patent/AU2020294627A1/en not_active Abandoned
- 2020-06-16 PH PH1/2021/553174A patent/PH12021553174A1/en unknown
- 2020-06-16 KR KR1020227001994A patent/KR20220046549A/ko not_active Ceased
- 2020-06-16 EP EP20826665.0A patent/EP3986413A4/en not_active Withdrawn
- 2020-06-16 CA CA3143043A patent/CA3143043A1/en active Pending
- 2020-06-16 BR BR112021025786A patent/BR112021025786A2/pt not_active Application Discontinuation
- 2020-06-16 PE PE2021002184A patent/PE20220135A1/es unknown
- 2020-06-16 CN CN202080044953.1A patent/CN114025765A/zh active Pending
- 2020-06-19 TW TW109120778A patent/TW202115090A/zh unknown
-
2021
- 2021-12-14 IL IL288982A patent/IL288982A/en unknown
-
2022
- 2022-01-19 CO CONC2022/0000405A patent/CO2022000405A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020257169A1 (en) | 2020-12-24 |
| MX2021015756A (es) | 2022-01-27 |
| AU2020294627A1 (en) | 2022-02-17 |
| IL288982A (en) | 2022-02-01 |
| PE20220135A1 (es) | 2022-01-27 |
| JP2022537385A (ja) | 2022-08-25 |
| BR112021025786A2 (pt) | 2022-02-01 |
| KR20220046549A (ko) | 2022-04-14 |
| CA3143043A1 (en) | 2020-12-24 |
| TW202115090A (zh) | 2021-04-16 |
| EP3986413A4 (en) | 2023-06-14 |
| CN114025765A (zh) | 2022-02-08 |
| CO2022000405A2 (es) | 2022-04-29 |
| US20220411439A1 (en) | 2022-12-29 |
| EP3986413A1 (en) | 2022-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4397665A3 (en) | Diaryl macrocycle polymorph | |
| GEP20247679B (en) | Bicyclic heterocycles as fgfr inhibitors | |
| WO2018141002A3 (en) | DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS | |
| MX2021001096A (es) | 7-bencil-4-(2-metilbencilo)-2,4,6,7,8,9-hexahidroimidazo [1,2-a]pirido[3,4-e]pirimidin-5(1h)-ona, analogos y sales del mismo y su uso en terapia. | |
| MX388140B (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret. | |
| MX2015012636A (es) | Terapia de combinacion de 7-bencil-10-(2-metilbencil)-2,6,7,8,9,10 -hexahidroimidazol[1,2-a] pirido [4,3-d] pirimidin-5(3h)-ona. | |
| MX2019004070A (es) | Sistema de extraccion de un sistema de circuito cerrado. | |
| EP4480543A3 (en) | Chiral diaryl macrocycle and use thereof in the treatment of cancer | |
| WO2006107771A3 (en) | PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS | |
| WO2013077921A3 (en) | Substituted pyrazolo[3,4-d]pyrimidines and uses thereof | |
| UY37559A (es) | Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton | |
| CL2011000119A1 (es) | Compuestos derivados de triazolo[4,3-a]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
| MX2021014674A (es) | Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas. | |
| PH12018500957A1 (en) | Imidazo[4,5-c] quinolin -2-one compounds and their use in treating cancer | |
| CL2011000116A1 (es) | Compuestos derivados de imidazo[1,2-a]piridina; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y uso en el tratamiento del cancer. | |
| UA99459C2 (en) | 9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer | |
| MX2025002794A (es) | Compuestos citotoxicos de imidazo[1,2-a]piridina y su uso en terapia | |
| MY150747A (en) | Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer | |
| MX2016015761A (es) | Derivados de amina de compuestos de 1-oxa-4,9-diazaespiro undecano que tienen actividad multimodal contra el dolor. | |
| MY209459A (en) | Peptide conjugates of microtubule-targeting agents as therapeutics | |
| WO2022058745A3 (en) | Imidazo[1,2-a]pyridine compounds and their use in therapy | |
| NI200700318A (es) | Benzocicloheptapiridinas como inhibidores de la tirosina quinasa de receptor met | |
| TW200635597A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
| PE20191789A1 (es) | Compuestos heterociclicos biciclicos sustituidos como inhibidores de la nadph oxidasa | |
| MA31630B1 (fr) | Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique |